BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 9, 1999
View Archived Issues
Theratechnologies and Atrix sign bone research collaboration
Read More
Licensing opportunity from NIH: antisense oligonucleotides for treating Crohn's disease
Read More
AS-924, a newly synthesized bifunctional ceftizoxime prodrug, shows good oral absorption
Read More
Lexicon Genetics grants sublicense to Avatar BioSci for use of gene-trapping technology
Read More
Axcan completes acquisition of 50% of Bonne Sante and Czet Pharma
Read More
Preliminary results of two Remune studies published in the Journal of Infectious Diseases
Read More
RPR reports new naphthyl-piperazinone antitumor agents
Read More
New NOS inhibitors in the pipeline at Schering AG
Read More
Topoisomerase poisons emerge from research at U.S. university
Read More
MCP-1/RANTES inhibitors in early development at AstraZeneca
Read More
Full agenda for next week's Oncologic Drugs Advisory Committee meeting
Read More
Relenza launched in U.K. in time for this year's flu season
Read More
Another market introduction for Merck's short-acting antiplatelet agent Aggrastat
Read More
Roberts to market Fareston in the U.S.
Read More
NexMed reports progress with topical treatments for sexual dysfunction
Read More
Atairgin and Washington State University to develop new therapeutic applications
Read More
Israeli group designs new family of nonpeptide, nonsulfhydryl Ras farnesylation inhibitors
Read More
Novartis initiates clinical trials using Emisphere's oral drug delivery technology
Read More
Two small-molecule anti-HIV compounds targeting gp41 identified at New York Blood Center
Read More
FDA approves new indications for Zerit and Videx
Read More
Rofecoxib, a new COX-2 inhibitor, effective against fever in monkeys and humans
Read More
Cellegy testosterone gel completes phase II trial
Read More
CAT and AstraZeneca form antibody research collaboration
Read More
InSite Vision receives milestone payment for ISV-205 development
Read More
Pyridorin enters clinical trials for treatment of diabetic kidney disease
Read More
BTS-79018 selected for clinical development as atypical antipsychotic agent
Read More
